Paloma Partners’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-29,609
Closed -$415K 2412
2020
Q3
$415K Buy
+29,609
New +$427K 0.01% 1288
2020
Q1
Sell
-27,135
Closed -$552K 2296
2019
Q4
$552K Sell
27,135
-1,556
-5% -$29.1K 0.01% 1342
2019
Q3
$477K Buy
28,691
+12,692
+79% +$220K 0.01% 1202
2019
Q2
$263K Sell
15,999
-20,688
-56% -$399K ﹤0.01% 1379
2019
Q1
$645K Buy
+36,687
New +$781K 0.02% 943
2018
Q2
Sell
-19,222
Closed -$762K 2348
2018
Q1
$762K Buy
19,222
+10,690
+125% +$415K 0.01% 1128
2017
Q4
$312K Sell
8,532
-581
-6% -$22K ﹤0.01% 1531
2017
Q3
$372K Buy
9,113
+494
+6% +$19.1K 0.01% 1698
2017
Q2
$344K Sell
8,619
-15,003
-64% -$502K ﹤0.01% 1745
2017
Q1
$687K Buy
+23,622
New +$623K 0.01% 1455
2016
Q2
Sell
-15,238
Closed -$154K 2396
2016
Q1
$154K Buy
+15,238
New +$171K ﹤0.01% 1731
2014
Q3
Sell
-15,428
Closed -$271K 1377
2014
Q2
$271K Buy
+15,428
New +$265K 0.01% 837

Other funds holding TVTY

Paloma Partners's TVTY Position: Q4 2020 in Review

Paloma Partners sold out of Tivity Health, Inc. Common Stock (TVTY) in Q4 2020, closing a stake of 29,609 shares — an estimated $415K sold.

Paloma Partners first reported a position in TVTY in Q2 2014 and held it in 12 quarters. The position peaked at $762K in Q1 2018. 158 funds tracked by Wall St. Rank hold TVTY as of Q4 2020.

  • Paloma Partners reported no remaining Tivity Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 29,609 Tivity Health, Inc. Common Stock shares in Q4 2020, an estimated $415K.
  • Paloma Partners first reported a position in Tivity Health, Inc. Common Stock in Q2 2014 and held it in 12 quarters.
  • Paloma Partners's Tivity Health, Inc. Common Stock position peaked at $762K in Q1 2018.
  • 158 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.